Nanobiotix S.A.
NBTX · NNBXF · Pharmaceutical Preparations
Latest available SEC filing: SCHEDULE 13G/A ·
Latest disclosures
-
Form SCHEDULE 13G/A
SEC filing · Filed
-
Latest financial period: Q4 2025
Financial facts · Filed
-
Form 20-F
SEC filing · Filed
-
Form SCHEDULE 13G
SEC filing · Filed
-
Form 20-F
SEC filing · Filed
-
Form 20-F
SEC filing · Filed
Institutional holders by security
Choose a share class to see reported 13F positions and quarterly changes. Different securities have separate holder histories.
- NBTX · 63009J107 - Ordinary shares, nominal value Euro 0.03 per share
Company details and SEC sources
CIK 0001760854 · SEC filing index. Filing dates describe disclosures, not live market data.
- Listed symbols
- NBTX on Nasdaq, NNBXF on OTC
- SEC industry group
- Pharmaceutical Preparations (Office of Life Sciences)
- Business address
- 60 Rue De Wattignies, Paris, France, 75012
- Incorporated in
- France
- Fiscal year end
- 31 December
At a glance
Names, identifiers, and filing context for this profile.
2 identity fields